Profile picture

Doctor Kensuke Matsushita

Yokochama City University Medical Centre, Yokohama (Japan)
Follow
Logo ESC

Contributor content

Computed tomography-derived myocardial extracellular volume: a diagnostic marker for cardiac amyloidosis in transcatheter aortic valve implantation patients with biopsy confirmation
Presentation
Computed tomography-derived myocardial extracellular volume: a diagnostic marker for cardiac amyloidosis in transcatheter aortic valve implantation patients with biopsy confirmation
Protective effects of dapagliflozin on vascular remodeling in the carotid artery following balloon injury - potential role of angiotensin and purinergic signaling
Presentation
Protective effects of dapagliflozin on vascular remodeling in the carotid artery following balloon injury - potential role of angiotensin and purinergic signaling
Primary hemostatic disorders drive early and late major bleedings of patients with atrial fibrillation after transcatheter aortic valve replacement
Presentation
Primary hemostatic disorders drive early and late major bleedings of patients with atrial fibrillation after transcatheter aortic valve replacement
Predictive impact of PVL assessments on clinical outcomes in patients undergoing TAVR
Presentation
Predictive impact of PVL assessments on clinical outcomes in patients undergoing TAVR
P2Y12 inhibition by clopidogrel increases adverse clinical outcomes in patients undergoing transcatheter aortic valve replacement
Presentation
P2Y12 inhibition by clopidogrel increases adverse clinical outcomes in patients undergoing transcatheter aortic valve replacement
Incomplete recovery of takotsubo cardiomyopathy is a major determinant of cardiovascular mortality
Presentation
Incomplete recovery of takotsubo cardiomyopathy is a major determinant of cardiovascular mortality
Impact of serum lipoprotein (a) level on coronary plaque progression and cardiovascular events in statin-treated patients with acute coronary syndrome.
Presentation
Impact of serum lipoprotein (a) level on coronary plaque progression and cardiovascular events in statin-treated patients with acute coronary syndrome.

ESC 365 is supported by